Suzhou Genassist Therapeutic Co. Ltd. has announced its pre-IND application of its first base-editing product, GEN-6050, and acceptance by the FDA. GEN-6050 is an in vivo base-editing drug that ...
The Data Distribution Service (DDS) standard has been around for many years (over 15 years actually) as a solution for connecting real-time distributed applications. While DDS first gained widespread ...
Santa Barbara, Calif. – Real-Time Innovation's DDS-compliant middleware now offers optimized support for Green Hills Software’s latest release of its safety and security-certified INTEGRITY real-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback